Tudor Investment Corp
ADVM

Tudor Investment Corp’s Adverum Biotechnologies ADVM Stock Holding History

Tudor Investment Corp’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,213
Closed -$7K – 2349
2022
Q4 		$7K Sell
1,213
-5,052
-81% -$38.3K ﹤0.01% 2282
2022
Q3 		$60K Buy
+6,265
New +$82.3K ﹤0.01% 2182
2016
Q2 		– Sell
-1,942
Closed -$100K – 1592
2016
Q1 		$100K Buy
+1,942
New +$108K ﹤0.01% 1614
2015
Q4 		– Sell
-1,220
Closed -$101K – 1614
2015
Q3 		$101K Sell
1,220
-1,090
-47% -$139K ﹤0.01% 1426
2015
Q2 		$375K Buy
+2,310
New +$779K 0.01% 962

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return

Tudor Investment Corp's ADVM Position: Q1 2023 in Review

Tudor Investment Corp sold out of Adverum Biotechnologies (ADVM) in Q1 2023, closing a stake of 1,213 shares — an estimated $7K sold.

Tudor Investment Corp first reported a position in ADVM in Q2 2015 and held it in 5 quarters. The position peaked at $375K in Q2 2015. 55 funds tracked by Wall St. Rank hold ADVM as of Q1 2023.

  • Tudor Investment Corp reported no remaining Adverum Biotechnologies position as of Q1 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 1,213 Adverum Biotechnologies shares in Q1 2023, an estimated $7K.
  • Tudor Investment Corp first reported a position in Adverum Biotechnologies in Q2 2015 and held it in 5 quarters.
  • Tudor Investment Corp's Adverum Biotechnologies position peaked at $375K in Q2 2015.
  • 55 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2023.

Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.